Short answer
aTYR PHARMA INC (ATYR) filed an 8-K current report with the SEC on October 27, 2026 reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws). 1-for-40 reverse split effective 5:00 p.m. ET October 28, 2026.
aTYR PHARMA INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- 1-for-40 reverse split effective 5:00 p.m. ET October 28, 2026
- Shares outstanding reduced from approximately 100.5 million to 2.5 million
- Authorized shares unchanged at 340 million, increasing potential post-split issuance capacity
- Options, RSUs and warrants adjusted proportionately, with higher exercise prices
- Nasdaq Capital Market trading under ATYR on split-adjusted basis October 29, 2026, new CUSIP 002120301
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other aTYR PHARMA INC 8-K filings
Get the next ATYR 8-K as it lands
Follow ATYR for push alerts, or ask the research agent what this filing means.